ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	16/190	79/7206	1.4608487281e-10
ko04974	Protein digestion and absorption	16/190	96/7206	3.02850701532e-09
ko00643	Styrene degradation	4/190	4/7206	4.68596994807e-07
ko04510	Focal adhesion	20/190	240/7206	4.49679026774e-06
ko04060	Cytokine-cytokine receptor interaction	15/190	191/7206	0.000145358970083
ko00350	Tyrosine metabolism	6/190	33/7206	0.000189908002343
ko05410	Hypertrophic cardiomyopathy (HCM)	10/190	100/7206	0.000282859155197
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	8/190	79/7206	0.0010607471574
ko05146	Amoebiasis	9/190	99/7206	0.00114069135522
ko04151	PI3K-Akt signaling pathway	21/190	390/7206	0.00163969403282
ko05133	Pertussis	8/190	87/7206	0.0019865909093
ko04810	Regulation of actin cytoskeleton	16/190	264/7206	0.00232491400611
ko05414	Dilated cardiomyopathy	9/190	112/7206	0.00270108686295
ko04640	Hematopoietic cell lineage	6/190	64/7206	0.00654506716619
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2/190	5/7206	0.00656249788679
ko05204	Chemical carcinogenesis	5/190	48/7206	0.00826063386438
ko00360	Phenylalanine metabolism	3/190	17/7206	0.00934111566596
ko00480	Glutathione metabolism	5/190	55/7206	0.0144823975878
ko04666	Fc gamma R-mediated phagocytosis	8/190	122/7206	0.0150393350822
ko04670	Leukocyte transendothelial migration	9/190	151/7206	0.0181045022793
ko00980	Metabolism of xenobiotics by cytochrome P450	4/190	40/7206	0.0204171861105
ko00401	Novobiocin biosynthesis	1/190	1/7206	0.0263669164585
ko04657	IL-17 signaling pathway	6/190	87/7206	0.0268945744397
ko05205	Proteoglycans in cancer	13/190	271/7206	0.0319694452719
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/190	11/7206	0.032526648431
ko04912	GnRH signaling pathway	7/190	122/7206	0.0419340828269
ko05145	Toxoplasmosis	7/190	126/7206	0.0484879256301